Long-Term Outcomes in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension From the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Registry (PHAROS)

Benzer Materyaller

• Survival in Systemic Sclerosis-Pulmonary Arterial Hypertension by Serum Autoantibody Status in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) Registry
  Yazar:: Hinchcliff, Monique, ve diğerleri
  Baskı/Yayın Bilgisi: (2015)
• Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS): Baseline Characteristics and Description of Study Population
  Yazar:: Hinchcliff, Monique, ve diğerleri
  Baskı/Yayın Bilgisi: (2011)
• Association between Initial Oral Therapy and Outcomes in Systemic Sclerosis-related Pulmonary Arterial Hypertension: Observations from PHAROS
  Yazar:: Lammi, Matthew R., ve diğerleri
  Baskı/Yayın Bilgisi: (2016)
• Changes in hemodynamic classification over time are common in systemic sclerosis-associated pulmonary hypertension: insights from the PHAROS cohort
  Yazar:: Lammi, Matthew R., ve diğerleri
  Baskı/Yayın Bilgisi: (2018)
• Collaborative National Quality and Efficacy Registry (CONQUER) for Scleroderma: outcomes from a multicenter US-based systemic sclerosis registry
  Yazar:: Shanmugam, Victoria K., ve diğerleri
  Baskı/Yayın Bilgisi: (2019)